The International URBAN Alcohol Research Collaboration on HIV/AIDS (ARCH) Center, funded by the National Institute on Alcohol Abuse and Alcoholism, conducts and disseminates interdisciplinary research on the role of alcohol use among people with HIV on new tuberculosis (TB) acquisition, occurrence of active TB disease after TB preventive therapy, and post-TB lung disease.


LATEST NEWS:

New Publication: Gabapentin to achieve HIV viral load suppression in people with risky drinking in Mbarara, Uganda: study protocol for a randomized, double-blinded, placebo-controlled trial (GRAIL). (Truong et al., 2026, Trials)

New Publication: Association Between Alcohol Use, CD4 Count, and Depressive Symptoms Among People with HIV with Viral Load Suppressed in Southwestern Uganda. (Favina et al., 2026, AIDS Behav)

New Publication: High Prevalence of Unhealthy Alcohol Use Among Persons with HIV, Viral Non-suppression and Any Alcohol Use in Mbarara, Uganda: A Brief Report. (Fisk-Hoffman et al., 2026, AIDS Behav)

New Publication: Intersectional Stigma and Health of People Living with HIV on ART Who Use Alcohol in Southwestern Uganda. (Gutin et al., 2026, AIDS Behav)

Check out the latest issue of the quarterly URBAN ARCH newsletter!

For quarterly updates from URBAN ARCH, click here to join our newsletter list!